Skip to main content
Clinical Trials/CTRI/2024/02/063321
CTRI/2024/02/063321
Not yet recruiting
未知

Evaluation of emerging inflammatory biomarkers in T2DM subjects across BMI spectrum. - NI

MAHE Manipal0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
MAHE Manipal
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
MAHE Manipal

Eligibility Criteria

Inclusion Criteria

  • Cases: Newly diagnosed cases of T2DM within 5 years of diagnosis, not on insulin, without any secondary complications of diabetes mellitus, will be included in the study.
  • Controls: Healthy individuals coming for routine health check up will be evaluated and recruited as controls.

Exclusion Criteria

  • Cases: Patients diagnosed with diabetes for a period of more than 5 years or patients with advanced micro and macrovascular complications of diabetes, or patients on insulin injections will be excluded from the study.
  • Controls: Patients diagnosed with diabetes, thyroid disorders, or any other chronic lifestyle diseases (except hypertension), patients with acute infective illness, and patients on drugs that might alter glucose homeostasis (such as corticosteroids), trauma patients, and pregnant women will be excluded from the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials